Patents by Inventor Eryk Thouin

Eryk Thouin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin Freceptor
    Patent number: 9073963
    Abstract: The invention relates to compositions which are useful for inhibiting prostaglandin F2? receptor. The compositions include, but are not limited to, linear peptides, peptide analogs, and peptidomimetics. Methods of using the compositions of the invention to treat preterm labor and dysmenorrhea are disclosed.
    Type: Grant
    Filed: April 15, 2009
    Date of Patent: July 7, 2015
    Assignees: Universite De Montreal, Theratechnologies, Inc.
    Inventors: Krishna Peri, Felix Polyak, William Lubell, Eryk Thouin, Sylvain Chemtob
  • PEPTIDES AND PEPTIDOMIMETICS USEFUL FOR INHIBITING THE ACTIVITY OF PROSTAGLANDIN F2alpha RECEPTOR
    Publication number: 20120172318
    Abstract: The invention relates to compositions which are useful for inhibiting prostaglandin F2? receptor. The compositions include, but are not limited to, linear peptides, peptide analogs, and peptidomimetics. Methods of using the compositions of the invention to treat preterm labor and dysmenorrhea are disclosed.
    Type: Application
    Filed: April 15, 2009
    Publication date: July 5, 2012
    Inventors: Krishna PERI, Felix POLYAK, William LUBELL, Eryk THOUIN, Sylvain CHEMTOB
  • 4-substituted piperidine derivatives
    Patent number: 7572913
    Abstract: Substituted piperidine compounds represented by the structure I are provided, wherein each of R1a, R1b, R1c, R1d, R1e, R1f, R1g, R1h, R2, R2A, R3, R4, A, X, a, x and n is as defined in the specification. Substituted piperidine compounds of structure I may permeate or penetrate across a nerve cell membrane into the interior of a nerve cell, may inhibit intracellular Rho kinase enzyme found in nerve cells in mammals, and may find utility in repair of damaged nerves in the central and peripheral nervous system of such mammals. These compounds may induce the regeneration or growth of neurites in mammalian nerve cells and may thereby induce regeneration of damaged or diseased nerve tissue. These compounds also find additional utility as antagonists of the enzyme Rho kinase in treatment of disease states in which Rho kinase is implicated.
    Type: Grant
    Filed: February 24, 2005
    Date of Patent: August 11, 2009
    Assignee: Bioaxone Therapeutique Inc.
    Inventors: Lisa McKerracher, Eryk Thouin, William Lubell, Robert Snow, Karine Gingras
  • Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin Freceptor
    Patent number: 7521530
    Abstract: The invention relates to compositions which are useful for inhibiting prostaglandin F2?receptor. The compositions include, but are not limited to, linear peptides, peptide analogs, and peptidomimetics. Methods of using the compositions of the invention to treat preterm labor and dysmenorrhea are disclosed.
    Type: Grant
    Filed: June 11, 2002
    Date of Patent: April 21, 2009
    Assignees: Universite De Montreal, Theratechnologies, Inc.
    Inventors: Krishna Peri, Felix Polyak, William Lubell, Eryk Thouin, Sylvain Chemtob
  • 4-Substituted piperidine derivatives
    Publication number: 20050272751
    Abstract: Substituted piperidine compounds represented by the structure I are provided, wherein each of R1a, R1b, R1c, R1d, R1e, R1f, R1g, R1h, R2, R2A, R3, R4, A, X, a, x and n is as defined in the specification. Substituted piperidine compounds of structure I may permeate or penetrate across a nerve cell membrane into the interior of a nerve cell, may inhibit intracellular Rho kinase enzyme found in nerve cells in mammals, and may find utility in repair of damaged nerves in the central and peripheral nervous system of such mammals. These compounds may induce the regeneration or growth of neurites in mammalian nerve cells and may thereby induce regeneration of damaged or diseased nerve tissue. These compounds also find additional utility as antagonists of the enzyme Rho kinase in treatment of disease states in which Rho kinase is implicated.
    Type: Application
    Filed: February 24, 2005
    Publication date: December 8, 2005
    Applicant: Bioaxone Therapeutique Inc.
    Inventors: Lisa McKerracher, Eryk Thouin, William Lubell, Robert Snow, Karine Gingras
  • 1,4-Substituted cyclohexane derivatives
    Publication number: 20040138272
    Abstract: Allylic compounds represented by the formula (I) are provided, 1
    Type: Application
    Filed: August 29, 2003
    Publication date: July 15, 2004
    Inventors: Lisa McKerracher, Eryk Thouin, William D. Lubell